Is There a Role for Perioperative Nutritional Support in Liver Resection? by Bothe, Albert & Steele, Glenn
HPB Surgery, 1997, Vol.10, pp. 177-193
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1997 OPA (Overseas Publishers Association)
Amsterdam B.V. Published in The Netherlands
by Harwood Academic Publishers
Printed in India
HPB INTERNATIONAL
EDITORIAL&ABSTRACTING SERVICE JOHNTERBLANCHE, EDITOR
Department ofSurgery,
Medical School. Observatory 7925
Cape Town. South Africa
Telephone: 27-21-406-6204
Telefax 27-21-448-6461
E-mail: JTER BLAN@UCT GSHI.UCT.AC.2A
IS THERE A ROLE FOR PERIOPERATIVE NUTRITIONAL
SUPPORT IN LIVER RESECTION?
ABSTRACT
Fan, S-T., Lo, C-M., Lao, E. C. S., Chu, K-M., Liu, C-L. and Wong, J. (1994)
Perioperative nutritional support in patients undergoing hepateetomy for hepato-
cellular carcinoma. New England Journal of Medicine; 331: 1547-1552.
Background: Resection of hepatocellular carcinoma is associated with high rates of
morbidity and mortality. Since intensive nutritional support can reduce the catabolic
response and improve protein synthesis and liver regeneration, we performed a prospec-
tive study to investigate whether perioperative nutritional support could improve out-
come in patients undergoing hepatectomy for hepatocellular carcinoma.
Methods: We studied 124 patients undergoing resection of hepatocellular carcinoma.
Sixty-four patients (39 with cirrhosis, 18 with chronic active hepatitis, and 7 with no
associated liver disease) were randomly assigned to receive perioperative intravenous
nutritional support in addition to their oral diet, and 60 patients (33 with cirrhosis, 12
with chronic active hepatitis, and 15 with no associated liver disease) were randomly
assigned to a control group. The perioperative nutritional therapy consisted of a
solution enriched with 35 percent branched chain amino acids, dextrose, and lipid
emulsion (50 percent medium-chain trigylcerides) given intravenously for 14 days
perioperatively).
Results: There was a reduction in the overall postoperative morbidity rate in the
perioperative-nutrition group as compared with the control group (34 percent vs. 55
percent; relative risk, 0.66; 95 percent confidence interval, 0.45 to 0.96), predomi-
nantly because of fewer septic complications (17 percent vs. 37 percent; relative risk,
0.57; 95 percent confidence interval, 0.34 to 0.96). There were also a reduction in the
requirement for diuretic agents to control ascites (25 percent vs. 50 percent; relative
risk, 0.57; 95 percent confidence interval, 0.37 to 0.87), less weight loss after
hepatectomy (median loss, 0 kg vs. 1.4 kg; P=0.01), and less deterioration of liver
function as measured by the change in the rate of clearance of indocyanine green
(-2.8 percent vs. -4.8 percent at 20 minutes, P=0.05). These benefits were seen
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predominantly in the patients with underlying cirrhosis who underwent major
hepatechtomy. There were five deaths during hospitalization in the perioperative-
nutrition group, and nine in the control group (P not significant).
Conclusions: Perioperative nutritional support can reduce complications after major
hepatectomy for hepatocellular carcinoma associated with cirrhosis. (N Engl J Med
1994; 331: 1547-52.)
KEYWORDS: Liver resection, hyperalimentation, cirrhosis
PAPERDISCUSSION
Since the study by Muller et al. more than a decade
ago showing the benefit of parenteral feeding in the
perioperative period, efforts have continued to refinethe
indications for nutritional support in the surgical pa-
tient. Fan and his colleagues have identified another
such specific group of patients. However, several re-
cent reports prompt caution before extrapolating the
finding to other patients. The large, prospective VA
Co-operative Study showed, by subset analysis, that
only severely malnourished surgical patients benefit
from parenteral nutrition support. In another study,
Sandstr6m
4was not able to demonstrate improved out-
come in a large group of 300 patients undergoing
major general surgical procedures, including 33
hepatectomies. Brennan et al. showed no benefit of
adjuvant parenteral nutrition in patients undergoing
major pancreatic resections. Further, that study
showed more complications in the TPN group.
Fan has studied the impact ofTPN on postoperative
complications after hepatectomy which has a histori-
cal high morbidity rate in his patient population. How-
ever, more recent publications by the same group6’7
reporl improved morbidity and mortality rates, em-
phasizing the importance ofconcurrent controls.
Like theVA Cooperative Study, patients in Fan’s study
had access to regular oral diets in the pre-operative pe-
riod. Thus, the parenteral nutrition group iscompared to
acontrol groupwithsome level ofundocumented nutrient
intake prior to surgery. The entire preoperative IV nutri-
ent feeding appears to have been provided to the treat-
ment group in an overnight bolus, in addition to daytime
oral feedings. Nutritional assessment parameters are re-
ported atrandomization, butnot prior to surgerywhich is
after seven days offeeding.
Analysis of the postoperative morbidity shows that
virtually all of the improvement in incidence of septic
complications in the treatment group is for pulmonary
infections, a difference not found in other recent studies.
It is also ofinterest that 4 ofthe 5 subphrenic abscesses
in the control group were lethal compared with no
deaths in the 4 patients in the treatment group with the
same complication. The development ofhepatic coma
postoperatively appears to have been uniformly lethal,
regardless ofnutritional support, though the definition
of coma is not provided. The high rate of need for
diuretic agents in the control group posed a clinical
problem, since the patients were simultaneously receiv-
ing 1.75 liters of crystalloid per day to match the fluid
volume of the TPN group. The statistically higher glu-
cose levels in the treatment group on days 2-5 may have
afforded an osmotic diuretic effect, especially noting the
wide upper ranges ofhyperglycemia reported.
Subgroup analysis shows a statistical reduction in
postoperative morbidity for the treatment group if cir-
rhosis was present or if the patient underwent major
hepatectomy. The small size ofthe subgroups obscures
the statistical benefit to cirrhotic patients if the proce-
dure is limited to a minor hepatectomy.
The fact that neither mortalitynor length-of-staywere
improved by nutritional support implies that the septic
complications which were more frequent in the control
group had limited clinical significance. Rather than ad-
vocating that perioperative intravenous nutritional sup-
port be used for all patients with hepatocellular
carcinoma undergoing hepatectomy, such nutritional
intervention might be limited to cirrhotic patients who
are to have major resections orwho have had significant
preoperative weight loss.
Further clinical studies might address the intriguing
animal model results of Delaney et al. suggesting that
enteral feeding is of greater benefit after hepatectomy
than parenteral feeding. Meanwhile, theworkbyFanand
his colleagues is another bit ofimportant information in
defining the disease-specific, procedure-specific and nu-
tritional-status-specific indications to be used in initiat-
ing an effective feeding strategy.
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STENT OR SURGERY FOR MALIGNANT LOW
BILEDUCT OBSTRUCTION?
ABSTRACT
Smith, A. C., Dowsett, J.F., Russell, R. C. G., Hatfield, A.R. W. and Cotton, P.B. (1994)
Randomised trial of endoscopic stenting versus surgical bypass in malignant low
bileduct obstruction. The Lancet; 344." 1655-1660.
The development of non-surgical techniques for the relief of malignant low bileduct
obstruction has cast doubt on the best way of relieving jaundice, particularly in patients
fit for surgery whose life expectancy is more than a few weeks.
We did a randomised prospective controlled trial comparing endoscopic stent inser-
tion and surgical biliary bypass in patients with malignant low bileduct obstruction.
204 patients were randomised (surgery 103, stent 101); 3 subsequently proved to have
benign disease and were excluded, leaving 101 surgical and 100 stented patients for
assessment. Technical success was achieved in 94 surgical and 95 stent patients, with
functional biliary decompression obtained in 92 patients in both groups. In stented
patients, there was a lower procedure-related mortality (3% vs 14%, p=0.01), major
complication rate (11% vs 29%, p=0.02), and median total hospital stay (20 vs 26 days,
p=0.001). Recurrent jaundice occurred in 36 stented patients and 2 surgical patients.
Late gastric outlet obstruction occurred in 17% of stented patients and 7% of the
surgical group. Despite the early benefits of stenting there was no significant difference
in overall survival between the two groups (median survival: surgical 26 weeks; stented
21 weeks; p=0.065).
Endoscopic stenting and surgery are effective palliative treatments with the former
having fewer early treatment-related complications and the latter fewer late complica-
tions.
Lancet 1994; 344:1655-60
KEYWORDS: Endoprothesis, Biliaryentericbypass, bileduct, carcinoma
pancreas